Microbot Medical Inc. 8-K

What Happened

• On June 23, 2026, Microbot Medical Inc. (MBOT) filed a Form 8‑K (Items 7.01 and 8.01) to disclose that a globally recognized academic center headquartered in Pennsylvania is the first facility in that state to adopt the company’s LIBERTY® Endovascular Robotic System. The company said it now has accounts in seven states across the Eastern U.S.
• The filing included a press release (Exhibit 99.1) and noted Regulation FD disclosure and customary forward‑looking statement language.

Key Details

• Filing date: June 23, 2026 (Form 8‑K, Items 7.01 and 8.01).
• First LIBERTY adoption in Pennsylvania; Microbot now has accounts in seven Eastern U.S. states.
• Press release attached as Exhibit 99.1; cover page interactive data included (Exhibit 104).
• No financial results, revenue figures, or contract terms were disclosed in the filing.

Why It Matters

• This announcement signals continued commercial progress and geographic expansion for Microbot’s LIBERTY endovascular robotic platform, demonstrating adoption at an academic medical center in a new state.
• For investors, the update is a non‑financial operational milestone that may indicate growing market acceptance; however, the 8‑K does not provide revenue impact, timing, or contract details.